Genetic aspects underlying the normocalcemic and hypercalcemic phenotypes of primary hyperparathyroidism
-
Published:2023-08-31
Issue:3
Volume:82
Page:646-653
-
ISSN:1559-0100
-
Container-title:Endocrine
-
language:en
-
Short-container-title:Endocrine
Author:
Viviani Arianna, Colangelo LucianoORCID, Ciminelli Bianca Maria, Novelletto Andrea, Sonato Chiara, Occhiuto Marco, Cipriani Cristiana, Diacinti Daniele, De Martino Viviana, Gianni Walter, Pepe Jessica, Minisola Salvatore, Malaspina Patrizia
Abstract
Abstract
Purpose
Hypercalcemic primary hyperparathyroidism (PHPT) is a common endocrine disorder that has been very well characterized. In contrast, many aspects of normocalcemic primary hyperparathyroidism (NPHPT) such as natural history, organ damage, and management are still matter of debate. In addition, both the pathophysiology and molecular basis of NPHPT are unclear. We investigated whether PHPT and NPHPT patient cohorts share the same pattern of genetic variation in genes known to be involved in calcium and/or bone metabolism.
Research design and methods
Genotyping for 9 single nucleotide polymorphisms (SNPs) was performed by Real-Time PCR (TaqMan assays) on 27 NPHPT and 31 PHPT patients evaluated in a tertiary referral Center. The data of both groups were compared with 54 in house-controls and 503 subjects from the 1000 Genomes Project. All groups were compared for allele/haplotype frequencies, on a single locus, two loci and multi-locus basis.
Results
The NPHPT group differed significantly at SNPs in OPG and ESR1. Also, the NPHPT cohort was peculiar for pairwise associations of genotypes and for the overrepresentation of unusual multilocus genotypes.
Conclusions
Our NPHPT patient set harbored a definitely larger quota of genetic diversity than the other samples. Specific genotypes may help in defining subgroups of NPHPT patients which deserve ad hoc clinical and follow-up studies.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference24 articles.
1. J.P. Bilezikian, A.A. Khan, S.J. Silverberg, G.E. Fuleihan, C. Marcocci, S. Minisola, N. Perrier, A. Sitges-Serra, R.V. Thakker, G. Guyatt, M. Mannstadt, J.T. Potts, B.L. Clarke, M.L. Brandi, Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J. Bone Miner. Res. 37, 2293–2314 (2022). https://doi.org/10.1002/jbmr.4677 2. S. Minisola, A. Arnold, Z. Belaya, M.L. Brandi, B.L. Clarke, F.M. Hannan, L.C. Hofbauer, K.L. Insogna, A. Lacroix, U. Liberman, Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism. J. Bone Min. Res. 37, 2315–2329 (2022). https://doi.org/10.1002/jbmr.4665 3. G. El-Hajj Fuleihan, M. Chakhtoura, C. Cipriani, R. Eastell, T. Karonova, J.-M. Liu, S. Minisola, A. Mithal, C.A. Moreira, M. Peacock, M. Schini, B. Silva, M. Walker, O. El Zein, C. Marcocci, Classical and nonclassical manifestations of primary hyperparathyroidism. J. Bone Min. Res. 37, 2330–2350 (2022). https://doi.org/10.1002/jbmr.4679 4. N.E. Cusano, N.M. Maalouf, P.Y. Wang, C. Zhang, S.C. Cremers, E.M. Haney, D.C. Bauer, E.S. Orwoll, J.P. Bilezikian, Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J. Clin. Endocrinol. Metab. 98, 2734–2741 (2013). https://doi.org/10.1210/jc.2013-1300 5. Palermo A., Naciu A.M., Tabacco G., Falcone S., Santonati A., Maggi D., D'Onofrio L., Briganti S.I., Castellitto D., Casini A., Pedone C., Lelli D., Fabbri A., Bilezikian J.P., Napoli N., Pozzilli P., Manfrini S., Cesareo R. Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 105 (2020). https://doi.org/10.1210/clinem/dgaa174
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|